{{Rsnum
|rsid=11641231
|Gene=POLR3GL
|Chromosome=16
|position=86347578
|Orientation=plus
|GMAF=0.2002
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=LINC00917
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 62.8 | 32.7 | 4.4
| HCB | 54.0 | 42.3 | 3.6
| JPT | 61.1 | 36.3 | 2.7
| YRI | 68.0 | 28.6 | 3.4
| ASW | 70.2 | 26.3 | 3.5
| CHB | 54.0 | 42.3 | 3.6
| CHD | 45.9 | 43.1 | 11.0
| GIH | 51.5 | 34.7 | 13.9
| LWK | 86.4 | 13.6 | 0.0
| MEX | 62.1 | 31.0 | 6.9
| MKK | 73.7 | 23.1 | 3.2
| TSI | 61.8 | 34.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20339536
|Trait=Response to statin therapy
|Title=Genome-wide association of lipid-lowering response to statins in combined study populations
|RiskAllele=G
|Pval=0.000008
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}